ReP USP - Resultado da busca

Artigo de periodico
PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients (2024)
Almeida, Anderson Rodrigues de ; Dantas, Andréa Tavares; Gonçalves, Maria Eduarda de Oliveira; Chêne, Charlotte ; Jeljeli, Mohamed ; Chouzenoux, Sandrine ; Thomas, Marine; Cunha, Eudes Gustavo Constantino ; Valadares, Lilian David de Azevedo ; Gomes, João Victor de Melo ; Paula, Simão Kalebe Silva de ; Pitta, Marina Galdino da Rocha ; Pitta, Ivan da Rocha ; Rêgo, Moacyr Jesus Barreto de Melo ; Pereira, Michelly Cristiny ; Duarte, Angela Luzia Branco Pinto; Abdalla, Dulcinéia Saes Parra ; Nicco, Carole ; Batteux, Frédéric ; Pitta, Maira Galdino da Rocha
Source: Inflammopharmacology. Unidade: FCF
Subjects: FIBROSE PULMONAR, CITOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Anderson Rodrigues de et al. PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients. Inflammopharmacology, v. 32, p. 433-446, 2024Tradução . . Disponível em: https://doi.org/10.1007/s10787-023-01296-9. Acesso em: 28 ago. 2024.
APA
Almeida, A. R. de, Dantas, A. T., Gonçalves, M. E. de O., Chêne, C., Jeljeli, M., Chouzenoux, S., et al. (2024). PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients. Inflammopharmacology, 32, 433-446. doi:10.1007/s10787-023-01296-9
NLM
Almeida AR de, Dantas AT, Gonçalves ME de O, Chêne C, Jeljeli M, Chouzenoux S, Thomas M, Cunha EGC, Valadares LD de A, Gomes JV de M, Paula SKS de, Pitta MG da R, Pitta I da R, Rêgo MJB de M, Pereira MC, Duarte ALBP, Abdalla DSP, Nicco C, Batteux F, Pitta MG da R. PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients [Internet]. Inflammopharmacology. 2024 ; 32 433-446.[citado 2024 ago. 28 ] Available from: https://doi.org/10.1007/s10787-023-01296-9
Vancouver
Almeida AR de, Dantas AT, Gonçalves ME de O, Chêne C, Jeljeli M, Chouzenoux S, Thomas M, Cunha EGC, Valadares LD de A, Gomes JV de M, Paula SKS de, Pitta MG da R, Pitta I da R, Rêgo MJB de M, Pereira MC, Duarte ALBP, Abdalla DSP, Nicco C, Batteux F, Pitta MG da R. PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients [Internet]. Inflammopharmacology. 2024 ; 32 433-446.[citado 2024 ago. 28 ] Available from: https://doi.org/10.1007/s10787-023-01296-9
Artigo de periodico
Factors associated with hospitalizations for Covid-19 in patients with rheumatoid arthritis: data from the Reumacov Brazil registry (2022)
Gomides, Ana Paula Monteiro; Albuquerque, Cleandro Pires de; Mota, Licia Maria Henrique da; Devide, Guilherme; Dias, Laiza Hombre; Duarte, Angela Luzia Branco Pinto; Giovelli, Raquel Altoe; Karnopp, Thais Evelyn; Lima, Hugo Deleon de; Shinjo, Samuel Katsuyuki
Source: Advances in rheumatology. Unidade: FM
Subjects: COVID-19, PACIENTES INTERNADOS, FATORES DE RISCO, ARTRITE REUMATOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMIDES, Ana Paula Monteiro et al. Factors associated with hospitalizations for Covid-19 in patients with rheumatoid arthritis: data from the Reumacov Brazil registry. Advances in rheumatology, v. 62, n. 1, 2022Tradução . . Disponível em: https://doi.org/10.1186/s42358-022-00244-5. Acesso em: 28 ago. 2024.
APA
Gomides, A. P. M., Albuquerque, C. P. de, Mota, L. M. H. da, Devide, G., Dias, L. H., Duarte, A. L. B. P., et al. (2022). Factors associated with hospitalizations for Covid-19 in patients with rheumatoid arthritis: data from the Reumacov Brazil registry. Advances in rheumatology, 62( 1). doi:10.1186/s42358-022-00244-5
NLM
Gomides APM, Albuquerque CP de, Mota LMH da, Devide G, Dias LH, Duarte ALBP, Giovelli RA, Karnopp TE, Lima HD de, Shinjo SK. Factors associated with hospitalizations for Covid-19 in patients with rheumatoid arthritis: data from the Reumacov Brazil registry [Internet]. Advances in rheumatology. 2022 ; 62( 1):[citado 2024 ago. 28 ] Available from: https://doi.org/10.1186/s42358-022-00244-5
Vancouver
Gomides APM, Albuquerque CP de, Mota LMH da, Devide G, Dias LH, Duarte ALBP, Giovelli RA, Karnopp TE, Lima HD de, Shinjo SK. Factors associated with hospitalizations for Covid-19 in patients with rheumatoid arthritis: data from the Reumacov Brazil registry [Internet]. Advances in rheumatology. 2022 ; 62( 1):[citado 2024 ago. 28 ] Available from: https://doi.org/10.1186/s42358-022-00244-5
Artigo de periodico
Increased levels of the soluble oncostatin M receptor (sOSMR) and glycoprotein 130 (sgp130) in systemic sclerosis patients and associations with clinical parameters (2020)
Almeida, Anderson Rodrigues de; Dantas, Andréa Tavares; Pereira, Michelly Cristiny; Rêgo, Moacyr Jesus Barreto de Melo; Gonçalves, Rafaela Silva Guimarães; Pitta, Ivan da Rocha; Duarte, Angela Luzia Branco Pinto; Abdalla, Dulcinéia Saes Parra ; Pitta, Maira Galdino da Rocha
Source: Immunobiology. Unidade: FCF
Subjects: CITOCINAS, AUTOIMUNIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Anderson Rodrigues de et al. Increased levels of the soluble oncostatin M receptor (sOSMR) and glycoprotein 130 (sgp130) in systemic sclerosis patients and associations with clinical parameters. Immunobiology, v. 225, p. 1-12, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.imbio.2020.15196. Acesso em: 28 ago. 2024.
APA
Almeida, A. R. de, Dantas, A. T., Pereira, M. C., Rêgo, M. J. B. de M., Gonçalves, R. S. G., Pitta, I. da R., et al. (2020). Increased levels of the soluble oncostatin M receptor (sOSMR) and glycoprotein 130 (sgp130) in systemic sclerosis patients and associations with clinical parameters. Immunobiology, 225, 1-12. doi:10.1016/j.imbio.2020.15196
NLM
Almeida AR de, Dantas AT, Pereira MC, Rêgo MJB de M, Gonçalves RSG, Pitta I da R, Duarte ALBP, Abdalla DSP, Pitta MG da R. Increased levels of the soluble oncostatin M receptor (sOSMR) and glycoprotein 130 (sgp130) in systemic sclerosis patients and associations with clinical parameters [Internet]. Immunobiology. 2020 ; 225 1-12.[citado 2024 ago. 28 ] Available from: https://doi.org/10.1016/j.imbio.2020.15196
Vancouver
Almeida AR de, Dantas AT, Pereira MC, Rêgo MJB de M, Gonçalves RSG, Pitta I da R, Duarte ALBP, Abdalla DSP, Pitta MG da R. Increased levels of the soluble oncostatin M receptor (sOSMR) and glycoprotein 130 (sgp130) in systemic sclerosis patients and associations with clinical parameters [Internet]. Immunobiology. 2020 ; 225 1-12.[citado 2024 ago. 28 ] Available from: https://doi.org/10.1016/j.imbio.2020.15196

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies

Non normalized affiliation